Eylea biosimilar injunction denial ‘negative’ for Regeneron, says UBS
An appeals court has upheld a District Court’s denial of a preliminary injunction for Amgen’s (AMGN) Eylea biosimilar, which UBS analyst Trung ...
The Philadelphia Tribune53m
Maryland moves to make medicine cheaper amid economic uncertainty
The Maryland General Assembly appears to be on its way to expanding the authority of its Prescription Drug Affordability ...